Skip to main content
. 2025 Sep 10;15(9):1304. doi: 10.3390/biom15091304
AEs Adverse Events
ASCO American Society of Clinical Oncology
AgNPs Silver Nanoparticles
AuNPs Gold Nanoparticles
BRCA1 Breast Cancer Gene 1
BRCA2 Breast Cancer Gene 2
CAR-T Chimeric Antigen Receptor T-cell
CAFs Cancer-Associated Fibroblasts
cfDNA Cell-Free DNA
CIMAC-CIDC Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons
CPS Combined Positive Score
CRC Colorectal Cancer
CTCs Circulating Tumor Cells
CTLA-4 Cytotoxic T Lymphocyte Associated Antigen 4
ctDNA Circulating Tumor DNA
dMMR Defective DNA Mismatch Repair
ELISA Enzyme-Linked Immunosorbent Assay
FITs Fecal Immunochemical Tests
FMT Fecal Microbiota Transplantation
FDA Food and Drug Administration
gFOBTs Guaiac-Based Fecal Occult Blood Tests
GPCRs G-Protein-Coupled Receptors
HLA Human Leukocyte Antigen
HNSCC Neck Squamous Cell Carcinoma
ICB Immune Checkpoint Blockade
ICIs Immune Checkpoint Inhibitors
IFN-γ Interferon Gamma
IHC Immunohistochemistry
IL-8 Interleukin-8
IrAEs Immune-Related Events
LAG-3 Lymphocyte-Activation Gene 3
MDSCs Myeloid-Derived Suppressor Cells
ML Machine Learning
MMRd Mismatch Repair Deficiency
MSI Microsatellite Instability
MSI-H High Microsatellite Instability
NCI National Cancer Institute
NK Natural killer
NSCLC Non-Small Cell Lung Cancer
NTRK Neurotrophic Tyrosine Receptor Kinase
ORR Overall Response Rates
PD-1 Programmed Death-1
PD-L1 Programmed Death-Ligand 1
PEG Polyethylene Glycol
PET Positron Emission Tomography
PFS Progression-Free Survival
PI3k Phosphatidylinositol 3-kinase
PKB Phosphorylated Protein Kinase B
SCFAs Short-Chain Fatty Acids
SERS Surface-Enhanced Raman Spectroscopy
TCGA The Cancer Genome Atlas
TILs Tumor-Infiltrating Lymphocytes
TMB Tumor Mutational Burden
TME Tumor Microenvironment